🔗 References (max. 100)
| part | subject | predicate | object | published by | date | |
|---|---|---|---|---|---|---|
|
Assertion
|
|
|||||
|
Assertion
|
In our study, extended-release dextroamphetamine-containing medications represented 8% (180/2233) of the overall off-label prescribing in children 3 to 5 years old and, as with methylphenidate, larger doses (25–30 mg) of dextroamphetamine were noted.
|
|
||||
|
Assertion
|
|
|||||
|
Assertion
|
|
|||||
|
Assertion
|
|
|||||
|
Assertion
|
|
|||||
|
Assertion
|
|
|||||
|
Assertion
|
|
|||||
|
Assertion
|
|
|||||
|
Assertion
|
|